Research News for January 2012
1–7 of 7 articles
-
About 25% of Women Need More Surgery After Lumpectomy
A study found that nearly 25% of women who had lumpectomy had to have more surgery after the pathology report was available.
-
Many Women Not Getting Recommended Breast Cancer Screening
National screening rates for colon, breast, and cervical cancer are low.
-
Abnormal Breast Cancer Gene May Improve Ovarian Cancer Prognosis
A study has found that among women diagnosed with ovarian cancer, women with an abnormal BRCA1 or BRCA2 gene have a better prognosis than women without an abnormal BRCA1 or BRCA2 gene.
-
Studies Evaluate Treatments Before Surgery for HER2-Positive Disease
Research suggests that using both Herceptin and Tykerb with Taxol before surgery to treat early-stage or locally advanced HER2-positive breast cancer is better than either alone with Taxol; if only one is given before surgery, Herceptin offers more benefits than Tykerb.
-
Analysis of Million Women Study Flawed, Link Between Hormone Replacement Therapy and Breast Cancer Remains
A group of experts reviewed the Million Women Study and concluded that it wasn't done properly.
-
Women Who Had Implant Reconstruction in Europe or Latin America Should Have Doctor Look at Implant
Women who had breast reconstruction surgery in European and Latin American countries using the PIP silicone breast implant are urged to have the implant evaluated by a doctor.
-
Most Women Share Genetic Test Results with Kids Even Though Value Isn’t Clear
Research has found that women who had abnormal breast cancer gene testing usually shared the test results with their children younger than 25, even though it's not clear that sharing the results with kids this young has value.
1–7 of 7 articles
